Ajax-Loading

Astellas Pharma Inc. - Total Long Term Debt

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Total-Long-Term-Debt" stands at 50.00 Billion Japanese Yens as of 06/30/2023.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 102.60 percent compared to the value the year prior.
The 1 year change in percent is 102.60.

The Serie's long term average value is 139.39 Billion Japanese Yens. It's latest available value, on 06/30/2023, is 64.13 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2023, to it's latest available value, on 06/30/2023, is +0.0%.
The Serie's change in percent from it's maximum value, on 09/30/2021, to it's latest available value, on 06/30/2023, is -75.59%.

Total Long Term Debt for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Total Long Term Debt905,699,262,464.00
LogoJohnson & Johnson - Total Long Term Debt486,508,953,600.00
LogoAbbVie Inc - Total Long Term Debt399,570,305,024.00
LogoRoche Holding AG - Total Long Term Debt317,433,206,677.55
LogoAstraZeneca PLC - Total Long Term Debt280,205,508,085.11